Elecnor Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

ElecnorDer Gewinn des Unternehmens wird voraussichtlich um 30.1% pro Jahr sinken, während der Jahresumsatz voraussichtlich um 2.8% pro Jahr wachsen wird. Der Gewinn pro Aktie wird voraussichtlich sinken um 41.8% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 6.9% betragen.

Wichtige Informationen

-30.1%

Wachstumsrate der Gewinne

-41.8%

EPS-Wachstumsrate

Construction Gewinnwachstum5.7%
Wachstumsrate der Einnahmen2.8%
Zukünftige Eigenkapitalrendite6.9%
Analystenabdeckung

Low

Zuletzt aktualisiert05 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Elecnor (BME:ENO) Is Increasing Its Dividend To €5.03

Nov 03
Elecnor (BME:ENO) Is Increasing Its Dividend To €5.03

Elecnor (BME:ENO) Has A Rock Solid Balance Sheet

Sep 18
Elecnor (BME:ENO) Has A Rock Solid Balance Sheet

The Price Is Right For Elecnor, S.A. (BME:ENO)

Aug 23
The Price Is Right For Elecnor, S.A. (BME:ENO)

Is Elecnor, S.A. (BME:ENO) Potentially Undervalued?

Jul 17
Is Elecnor, S.A. (BME:ENO) Potentially Undervalued?

Elecnor's (BME:ENO) Dividend Will Be Increased To €0.3137

May 26
Elecnor's (BME:ENO) Dividend Will Be Increased To €0.3137

These 4 Measures Indicate That Elecnor (BME:ENO) Is Using Debt Reasonably Well

Mar 06
These 4 Measures Indicate That Elecnor (BME:ENO) Is Using Debt Reasonably Well

Is Elecnor, S.A. (BME:ENO) Worth €18.7 Based On Its Intrinsic Value?

Dec 11
Is Elecnor, S.A. (BME:ENO) Worth €18.7 Based On Its Intrinsic Value?

We Think Elecnor (BME:ENO) Is Taking Some Risk With Its Debt

Aug 23
We Think Elecnor (BME:ENO) Is Taking Some Risk With Its Debt

Elecnor (BME:ENO) Has Announced That It Will Be Increasing Its Dividend To €0.292

May 21
Elecnor (BME:ENO) Has Announced That It Will Be Increasing Its Dividend To €0.292

Does Elecnor (BME:ENO) Have A Healthy Balance Sheet?

Sep 24
Does Elecnor (BME:ENO) Have A Healthy Balance Sheet?

Returns Are Gaining Momentum At Elecnor (BME:ENO)

May 19
Returns Are Gaining Momentum At Elecnor (BME:ENO)

Is Elecnor, S.A. (BME:ENO) The Right Choice For A Smart Dividend Investor?

May 01
Is Elecnor, S.A. (BME:ENO) The Right Choice For A Smart Dividend Investor?

Elecnor (BME:ENO) Has A Pretty Healthy Balance Sheet

Mar 16
Elecnor (BME:ENO) Has A Pretty Healthy Balance Sheet

Elecnor (BME:ENO) Shareholders Have Enjoyed A 56% Share Price Gain

Mar 01
Elecnor (BME:ENO) Shareholders Have Enjoyed A 56% Share Price Gain

Returns On Capital At Elecnor (BME:ENO) Paint An Interesting Picture

Feb 11
Returns On Capital At Elecnor (BME:ENO) Paint An Interesting Picture

Elecnor, S.A. (BME:ENO) Vies For A Place In Your Dividend Portfolio: Here's Why

Jan 25
Elecnor, S.A. (BME:ENO) Vies For A Place In Your Dividend Portfolio: Here's Why

Is Elecnor, S.A.'s (BME:ENO) ROE Of 21% Impressive?

Jan 07
Is Elecnor, S.A.'s (BME:ENO) ROE Of 21% Impressive?

What Kind Of Investors Own Most Of Elecnor, S.A. (BME:ENO)?

Dec 18
What Kind Of Investors Own Most Of Elecnor, S.A. (BME:ENO)?

Elecnor (BME:ENO) Could Be A Buy For Its Upcoming Dividend

Dec 02
Elecnor (BME:ENO) Could Be A Buy For Its Upcoming Dividend

Are Insiders Selling Elecnor, S.A. (BME:ENO) Stock?

Nov 30
Are Insiders Selling Elecnor, S.A. (BME:ENO) Stock?

Gewinn- und Umsatzwachstumsprognosen

BME:ENO - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20264,07073-341572
12/31/20254,00172-791352
12/31/20243,864476-41303
6/30/20243,80646174284N/A
3/31/20243,97545N/AN/AN/A
12/31/20233,88263112206N/A
6/30/20233,63338133221N/A
3/31/20233,747105N/AN/AN/A
12/31/20223,42145144227N/A
9/30/20223,56596N/AN/AN/A
6/30/20223,3899245142N/A
3/31/20223,27990N/AN/AN/A
12/31/20213,1338698206N/A
9/30/20212,97383N/AN/AN/A
6/30/20212,8088217206N/A
3/31/20212,53879N/AN/AN/A
12/31/20202,49878-36194N/A
9/30/20202,418125N/AN/AN/A
6/30/20202,41112389259N/A
3/31/20202,465125N/AN/AN/A
12/31/20192,478126109231N/A
9/30/20192,29777N/AN/AN/A
6/30/20192,276845592N/A
3/31/20192,28675N/AN/AN/A
12/31/20182,25682132168N/A
9/30/20182,31873N/AN/AN/A
6/30/20182,3147356174N/A
3/31/20182,32672N/AN/AN/A
12/31/20172,31771N/A43N/A
9/30/20172,27570N/AN/AN/A
6/30/20172,17470N/A81N/A
3/31/20172,09469N/AN/AN/A
12/31/20162,03568N/A198N/A
9/30/20161,93968N/AN/AN/A
6/30/20161,92367N/A216N/A
3/31/20161,90766N/AN/AN/A
12/31/20151,88166N/A237N/A
9/30/20151,88165N/AN/AN/A
6/30/20151,84961N/A204N/A
3/31/20151,74659N/AN/AN/A
12/31/20141,72459N/A-78N/A
9/30/20141,64540N/AN/AN/A
6/30/20141,64134N/A35N/A
3/31/20141,85350N/AN/AN/A
12/31/20131,86453N/A43N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: ENOFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-30.1% pro Jahr).

Ertrag vs. Markt: ENOFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-30.1% pro Jahr).

Hohe Wachstumserträge: ENOFür die nächsten 3 Jahre wird mit einem Rückgang der Erträge gerechnet.

Einnahmen vs. Markt: ENODie Einnahmen des Unternehmens (2.8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Spanish (4.9% pro Jahr).

Hohe Wachstumseinnahmen: ENODie Einnahmen des Unternehmens (2.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: ENODie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (6.9%).


Wachstumsunternehmen entdecken